Insights On Trial Design

  1. Clinical Trial Support: Point Of Need vs. Traditional Solutions 7/24/2025

    Examine the limitations of traditional, fixed-location ophthalmic trial sites and how a mobile assessment model can significantly improve patient retention while ensuring high-quality data collection.

  2. Scaling Oncology Trials Without Losing Momentum 5/1/2026

    As oncology programs expand, complexity often replaces momentum. Explore how scaling introduces hidden operational challenges and why anticipating continuity early helps teams stay aligned.

  3. Tips For Conducting Early-Phase Cancer Trials In Australia 9/23/2025

    Fast-track your early-phase cancer trial in Australia with world-class sites, expert teams, and streamlined regulatory approval.

  4. Early Planning Makes Clinical Research Meetings More Effective 3/20/2026

    Starting earlier can dramatically improve clinical research meetings. Explore how timing affects your choices and why identifying non-negotiables first helps teams manage meeting budgets.

  5. Health Economics And Outcomes Research (HEOR) Explained 7/15/2025

    Learn about this accessible way to understand what HEOR is, how it’s used, and its impact on people and healthcare systems.

  6. Busting Through Patient Recruitment Barriers 12/8/2025

    Building patient trust fuels engagement, data and technology enable targeted recruitment, and real-time patient identification with consistent support drives scalable enrollment success.

  7. Early Immune Profiling With In Vivo, In Vitro, And Ex Vivo Systems 10/7/2025

    Modern biologics increasingly interact with the immune system. While these innovations enable transformative therapies, they can also provoke acute immune activation during first-in-human (FIH) trials.

  8. What Does 2025 Hold For Pharma? 1/17/2025

    Look at what’s in store for pharma and life science in 2025. While we see many recurring themes, 2025 promises to be filled with unexpected — and possibly unprecedented — developments.

  9. Reduce Avoidable Protocol Amendments By Anticipating Operational Pitfalls 5/13/2026

    This report examines how amendment drivers vary across therapeutic areas and how those changes impact execution, patient burden, site workload, timelines, and study costs.

  10. Overcoming Complex Patient Recruitment Challenges With Data 4/15/2025

    Overcome roadblocks to recruiting patients for rare disease clinical trials with RWD and RWE, including lack of diagnosis and stringent I/E criteria, geographic dispersion, and high dropout rates.